Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia To Consider New Drug Price Caps In Next Year’s Budget

This article was originally published in PharmAsia News

Executive Summary

Australia's federal government plans to lower the caps on the price of the medicines it covers when it considers next year's budget later this year. Drug makers are being advised by the Health Ministry that the budget might go after company profits if the current practice of discounts and incentives to pharmacists to push drugs is not restrained. The discounts get passed on to the consumer, Minister Nicola Roxon said, and the government does not feel the Pharmaceutical Benefits Scheme should be propping up industry profits, particularly in the current economic climate. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071687

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel